,mean_rank,weight
cervix,8.0,3.0
lung carcinoma,25.0,1.0
adrenal gland,33.0,3.0
supraclavicular lymph node,43.0,3.0
right anterior leg,45.0,3.0
small cell lung carcinoma,47.5,88.0
medulloblastoma,49.5,8.0
thyroid gland squamous cell carcinoma,50.0,3.0
neuroblastoma,54.5,52.0
adrenal gland neuroblastoma,65.0,5.0
embryonal carcinoma,73.0,1.0
rhabdomyosarcoma,79.0,4.0
lung carcinoid tumor,91.0,6.0
cervical small cell carcinoma,92.0,1.0
ewing sarcoma,94.0,31.0
mediastinal lymph node,97.0,1.0
natural killer cell lymphoblastic leukemia/lymphoma,105.0,1.0
oligodendroglioma,112.0,5.0
ovarian granulosa cell tumor,116.5,2.0
pancreatic somatostatinoma,117.0,3.0
endometrioid stromal sarcoma,119.0,3.0
right thigh skin,123.0,2.0
axillary lymph node,127.5,6.0
hereditary thyroid gland medullary carcinoma,130.0,1.0
multiple endocrine neoplasia type 2,130.0,1.0
testicular embryonal carcinoma,134.0,1.0
peritoneal ascites,135.5,2.0
primitive neuroectodermal tumor,148.5,2.0
ovarian leiomyosarcoma,150.0,3.0
myeloid leukemia associated with down syndrome,151.0,1.0
brain,153.0,16.0
not specified,157.0,3.0
neurofibromatosis type 1,158.0,1.0
embryonal rhabdomyosarcoma,161.0,6.0
large cell lung carcinoma,161.5,32.0
gastric small cell neuroendocrine carcinoma,164.0,4.0
prostate carcinoma,167.0,11.0
lung giant cell carcinoma,168.5,4.0
alveolar rhabdomyosarcoma,170.0,9.0
uterine carcinosarcoma,176.5,2.0
abdomen,178.5,2.0
vertebra,178.5,2.0
inguinal lymph node,182.0,3.0
pelvic wall,184.0,3.0
right pararenal lymph node,187.5,2.0
lymphoma,189.0,1.0
pharyngeal squamous cell carcinoma,191.0,3.0
askin tumor,192.0,2.0
ovarian carcinoma,192.5,6.0
subserosa of fallopian tube,200.0,1.0
osteosarcoma,202.0,23.0
high grade ovarian serous adenocarcinoma,202.0,40.0
papillary renal cell carcinoma,205.0,5.0
supra-orbital region,218.0,1.0
cutaneous melanoma,219.5,26.0
skin nodule,221.0,1.0
gliosarcoma,221.5,6.0
thyroid gland follicular carcinoma,222.0,10.0
chondrosarcoma,222.5,10.0
bone marrow,223.0,65.0
left leg muscle,227.0,3.0
ovarian serous cystadenocarcinoma,229.0,4.0
brca1 syndrome,230.0,1.0
squamous cell lung carcinoma,242.0,48.0
ovarian endometrioid adenocarcinoma,245.0,11.0
melanoma,248.0,94.0
groin lymph node,254.0,5.0
amelanotic melanoma,269.0,16.0
"squamous cell breast carcinoma, acantholytic variant",270.0,3.0
astrocytoma,271.0,19.0
n/a,271.5,34.0
hodgkin lymphoma,272.0,11.0
subcutaneous,274.0,7.0
thyroid gland sarcoma,277.0,1.0
rhabdoid tumor of the kidney,277.0,3.0
thyroid gland undifferentiated (anaplastic) carcinoma,279.0,13.0
ovarian mixed germ cell tumor,279.0,1.0
intraperitoneal,282.0,1.0
adenosquamous lung carcinoma,283.0,9.0
erythroleukemia,283.0,3.0
endometrial adenosquamous carcinoma,285.0,6.0
poorly differentiated thyroid gland carcinoma,285.0,3.0
squamous papilloma,288.0,1.0
vaginal melanoma,291.0,1.0
cerebrospinal fluid,292.0,3.0
plasma cell myeloma,292.0,30.0
liposarcoma,296.0,1.0
childhood acute myeloid leukemia with maturation,297.0,1.0
glioblastoma,304.0,84.0
endometrial carcinoma,305.0,8.0
pleural epithelioid mesothelioma,307.5,18.0
hepatocellular carcinoma,308.0,51.0
ovarian serous adenocarcinoma,311.0,7.0
abdominal wall,311.5,2.0
mucinous gastric adenocarcinoma,322.0,3.0
minimally invasive lung adenocarcinoma,322.5,16.0
mantle cell lymphoma,329.5,6.0
pleural effusion,333.0,224.0
splenic lymphoma with circulating villous lymphocytes,335.0,1.0
primary effusion lymphoma,338.0,3.0
b-cell prolymphocytic leukemia,342.0,2.0
hereditary spherocytosis,346.0,1.0
chronic lymphocytic leukemia,346.5,2.0
lymph node,350.0,105.0
acute myeloid leukemia,351.0,1.0
ascites,352.0,103.0
anaplastic large cell lymphoma,352.0,8.0
salivary gland squamous cell carcinoma,352.0,3.0
vulvar leiomyosarcoma,353.0,3.0
pleural sarcomatoid mesothelioma,355.5,8.0
duodenal adenocarcinoma,361.0,1.0
lung,363.0,7.0
breast carcinoma,364.0,27.0
lung adenocarcinoma,365.0,145.0
gastric adenosquamous carcinoma,366.0,2.0
hypopharyngeal squamous cell carcinoma,370.0,5.0
clear cell renal cell carcinoma,373.0,18.0
gastric carcinoma,373.0,12.0
childhood acute myeloid leukemia,374.5,2.0
pleural biphasic mesothelioma,375.0,7.0
subcutaneous; right buttock,375.0,3.0
fibrosarcoma,378.0,5.0
spleen,387.0,3.0
lung mucoepidermoid carcinoma,389.0,3.0
marek disease,391.0,1.0
renal cell carcinoma,393.0,37.0
anaplastic astrocytoma,396.0,5.0
"chronic eosinophilic leukemia, not otherwise specified",397.0,1.0
peripheral blood,398.0,107.0
bladder carcinoma,399.0,51.0
adult acute monocytic leukemia,401.0,5.0
intrahepatic cholangiocarcinoma,401.0,6.0
ovarian mucinous adenocarcinoma,403.5,4.0
adult b acute lymphoblastic leukemia,406.0,3.0
celiac axis lymph node,407.5,2.0
bladder squamous cell carcinoma,409.0,3.0
b acute lymphoblastic leukemia,410.0,5.0
epstein-barr virus-related burkitt lymphoma,413.5,10.0
"chronic myelogenous leukemia, bcr-abl1 positive",414.0,16.0
"invasive ductal carcinoma, not otherwise specified",415.0,30.0
breast adenocarcinoma,419.0,23.0
childhood t acute lymphoblastic leukemia,421.0,19.0
esophageal squamous cell carcinoma,422.0,59.0
burkitt lymphoma,428.0,8.0
ovarian clear cell adenocarcinoma,431.0,13.0
thigh skin,432.0,1.0
pericardial effusion,432.5,8.0
cervical squamous cell carcinoma,433.0,1.0
uterine corpus sarcoma,437.0,3.0
ductal breast carcinoma,440.5,32.0
mediastinal (thymic) large b-cell lymphoma,441.0,1.0
epithelioid cell type gastrointestinal stromal tumor,444.0,3.0
hepatoblastoma,447.5,4.0
diffuse large b-cell lymphoma germinal center b-cell type,452.0,8.0
endometrial adenocarcinoma,454.0,34.0
left supraclavicular lymph node,458.0,4.0
biphasic synovial sarcoma,461.0,1.0
adrenal cortex carcinoma,465.0,1.0
gastric adenocarcinoma,465.5,26.0
b acute lymphoblastic leukemia with t(v;11q23) kmt2a rearranged,467.0,3.0
laryngeal squamous cell carcinoma,467.0,12.0
omentum,467.0,7.0
thoracic lymph duct,469.0,1.0
pancreatic carcinoma,471.0,12.0
pancreatic adenosquamous carcinoma,472.0,5.0
cutaneous t-cell non-hodgkin lymphoma,473.5,2.0
myelodysplastic syndrome,474.0,1.0
gastric tubular adenocarcinoma,475.0,11.0
liver,476.0,32.0
malignant ovarian brenner tumor,481.0,1.0
recurrent bladder carcinoma,483.0,3.0
oral cavity squamous cell carcinoma,483.5,6.0
pancreatic adenocarcinoma,485.0,39.0
brachialis muscle,486.0,3.0
"childhood chronic myelogenous leukemia, bcr-abl1 positive",488.5,2.0
pleural malignant mesothelioma,491.0,5.0
human papillomavirus-related endocervical adenocarcinoma,491.0,4.0
pancreatic ductal adenocarcinoma,496.0,39.0
ovarian cystadenocarcinoma,498.0,6.0
non-small cell lung carcinoma,499.5,24.0
gingival squamous cell carcinoma,500.0,2.0
colon adenocarcinoma,501.0,61.0
diffuse large b-cell lymphoma,502.5,20.0
gestational choriocarcinoma,504.5,2.0
cecum adenocarcinoma,505.5,18.0
adult t acute lymphoblastic leukemia,506.0,5.0
invasive lobular breast carcinoma,511.0,1.0
ovarian adenocarcinoma,520.0,5.0
follicular lymphoma,522.5,2.0
tongue squamous cell carcinoma,526.5,34.0
childhood b acute lymphoblastic leukemia,527.0,9.0
ovarian mucinous cystadenocarcinoma,527.5,2.0
b-cell non-hodgkin lymphoma,529.0,7.0
bronchogenic carcinoma,530.0,2.0
ampulla of vater adenocarcinoma,538.5,2.0
"endometrial endometrioid adenocarcinoma, variant with squamous differentiation",539.0,2.0
tonsillar squamous cell carcinoma,541.0,1.0
down syndrome,544.0,2.0
childhood t lymphoblastic lymphoma,544.0,2.0
acute promyelocytic leukemia with t(15;17)(q22;q12) pml-rara,545.0,1.0
brca2 syndrome,548.0,1.0
undifferentiated pleomorphic sarcoma,550.5,4.0
cervical lymph node,552.0,5.0
uterine corpus leiomyosarcoma,554.0,3.0
colon carcinoma,561.0,19.0
peritoneal effusion,561.5,6.0
obturator lymph node,570.0,3.0
signet ring cell gastric adenocarcinoma,578.0,9.0
rectosigmoid adenocarcinoma,583.0,3.0
peritoneum,586.0,1.0
adult acute myeloid leukemia,587.0,22.0
barrett adenocarcinoma,588.0,3.0
skin squamous cell carcinoma,588.0,1.0
right axillary lymph node,593.0,1.0
familial adenomatous polyposis,596.0,1.0
rectal adenocarcinoma,598.0,11.0
hilar cholangiocarcinoma,599.0,1.0
small intestine,600.0,1.0
mycosis fungoides and sezary syndrome,610.5,2.0
undifferentiated gallbladder carcinoma,619.0,1.0
buttock,622.5,2.0
b acute lymphoblastic leukemia with t(1;19)(q23;p13.3) e2a-pbx1 (tcf3-pbx1),627.0,4.0
papillary lung adenocarcinoma,627.0,3.0
gallbladder carcinoma,629.5,2.0
cystic fibrosis,639.0,2.0
hairy cell leukemia,644.0,3.0
pelvis; innominate bone,645.5,2.0
skin,662.0,3.0
paragastric lymph node,680.5,2.0
mandible,688.0,1.0
gastric choriocarcinoma,690.0,1.0
lymphoblastic lymphoma,707.0,1.0
vulvar melanoma,732.0,1.0
cholangiocarcinoma,744.5,2.0
vulvar carcinoma,748.0,1.0
vulvar squamous cell carcinoma,763.0,3.0
diffuse large b-cell lymphoma activated b-cell type,764.0,1.0
gastric fundus carcinoma,768.0,1.0
floor of mouth squamous cell carcinoma,777.0,1.0
head and neck squamous cell carcinoma,788.0,9.0
human papillomavirus-related cervical squamous cell carcinoma,790.5,8.0
esophageal adenocarcinoma,791.0,9.0
bone,792.0,1.0
epithelioid sarcoma,795.0,1.0
buccal mucosa squamous cell carcinoma,818.5,2.0
childhood acute monocytic leukemia,832.0,2.0
cervical carcinoma,863.0,2.0
oral dysplasia,906.0,1.0
acute myelomonocytic leukemia,917.0,1.0
meninges,917.0,1.0
thyroid gland papillary carcinoma,935.0,1.0
left cervical lymph node,935.0,1.0
parotid gland mucoepidermoid carcinoma,936.0,1.0
pyriform fossa squamous cell carcinoma,953.0,1.0
benign prostatic hyperplasia,958.0,1.0
ovary,962.0,1.0
squamous cell carcinoma,967.0,1.0
